{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:58:38Z","timestamp":1793735918133,"version":"4.6.1"},"reference-count":150,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology International"],"abstract":"<jats:p>Coagulation and fibrinolytic system disorders are conditions in which the blood\u2019s ability to clot is impaired, resulting in an increased risk of thrombosis or bleeding. Although these disorders are the expression of two opposing tendencies, they can often be associated with or be a consequence of each other, contributing to making the prognosis of acute cerebrovascular events more difficult. It is important to recognize those conditions that are characterized by dual alterations in the coagulation and fibrinolytic systems to reduce the prognostic impact of clinical conditions with difficult treatment and often unfortunate outcomes. Management of these individuals can be challenging, as clinicians must balance the need to prevent bleeding episodes with the potential risk of clot formation. Treatment decisions should be made on an individual basis, considering the specific bleeding disorder, its severity, and the patient\u2019s general medical condition. This review aims to deal with all those forms in which coagulation and fibrinolysis represent two sides of the same media in the correct management of patients with acute neurological syndrome. Precision medicine, personalized treatment, advanced anticoagulant strategies, and innovations in bleeding control represent future directions in the management of these complex pathologies in which stroke can be the evolution of two different acute events or be the first manifestation of an occult or unknown underlying pathology.<\/jats:p>","DOI":"10.3390\/neurolint15040093","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T04:12:56Z","timestamp":1701403976000},"page":"1443-1458","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hemorrhagic Coagulation Disorders and Ischemic Stroke: How to Reconcile Both?"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9793-0794","authenticated-orcid":false,"given":"Pietro","family":"Crispino","sequence":"first","affiliation":[{"name":"Medicine Unit, Santa Maria Goretti Hospital, Via Scaravelli Snc, 04100 Latina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"113541","DOI":"10.1016\/j.expneurol.2020.113541","article-title":"Hyperhomocysteinemia is an emerging comorbidity in ischemic stroke","volume":"336","author":"Poddar","year":"2020","journal-title":"Exp. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/B978-0-7020-4087-0.00071-1","article-title":"Thrombophilic states","volume":"120","author":"Martinelli","year":"2014","journal-title":"Handb. Clin. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ciarambino, T., Crispino, P., Minervini, G., and Giordano, M. (2023). Cerebral Sinus Vein Thrombosis and Gender: A Not Entirely Casual Relationship. Biomedicines, 11.","DOI":"10.3390\/biomedicines11051280"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Ciarambino, T., Crispino, P., Mastrolorenzo, E., Viceconti, A., and Giordano, M. (2022). Stroke and Etiopathogenesis: What Is Known?. Genes, 13.","DOI":"10.3390\/genes13060978"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00002512-199506010-00004","article-title":"Anticoagulants in older patients. A safety perspective","volume":"6","author":"Beyth","year":"1995","journal-title":"Drugs Aging"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/pds.2109","article-title":"An automated database case definition for serious bleeding related to oral anticoagulant use","volume":"20","author":"Cunningham","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e030879","DOI":"10.1161\/JAHA.123.030879","article-title":"Real-World Evidence on Disparities on the Initiation of Ticagrelor Versus Prasugrel in Patients with Acute Coronary Syndrome","volume":"12","author":"Yildirim","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes","volume":"357","author":"Wiviott","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","article-title":"The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: The RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy)","volume":"63","author":"Reilly","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ahj.2015.07.006","article-title":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)","volume":"170","author":"Bansilal","year":"2015","journal-title":"Am. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1002\/clc.23178","article-title":"Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial","volume":"42","author":"Pokorney","year":"2019","journal-title":"Clin. Cardiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e003432","DOI":"10.1161\/JAHA.116.003432","article-title":"Efficacy and Safety of Edoxaban in Elderly Patients with Atrial Fibrillation in the ENGAGE AF\u2013TIMI 48 Trial","volume":"5","author":"Kato","year":"2016","journal-title":"J. Am. Heart Assoc."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.2105\/AJPH.2009.162982","article-title":"Disparate Inclusion of Older Adults in Clinical Trials: Priorities and Opportunities for Policy and Practice Change","volume":"100","author":"Herrera","year":"2010","journal-title":"Am. J. Public Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1056\/NEJM199312303292710","article-title":"Evaluating Drugs after Their Approval for Clinical Use","volume":"329","author":"Ray","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cts.13438","article-title":"Factors related to polypharmacy and hyper-polypharmacy for the elderly: A nationwide cohort study using National Health Insurance data in South Korea","volume":"16","author":"Cho","year":"2022","journal-title":"Clin. Transl. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archinte.165.10.1095","article-title":"Systematic Overview of Warfarin and Its Drug and Food Interactions","volume":"165","author":"Holbrook","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e019672","DOI":"10.1136\/bmjopen-2017-019672","article-title":"Resuming anticoagulants after anticoagulation-associated intracranial haemorrhage: Systematic review and meta-analysis","volume":"8","author":"Zhou","year":"2018","journal-title":"BMJ Open"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12325-022-02333-9","article-title":"Risk and Management of Bleeding Complications with Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Venous Thromboembolism: A Narrative Review","volume":"40","author":"Ballestri","year":"2023","journal-title":"Adv. Ther."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1001\/archinte.1993.00410140047006","article-title":"Concurrent Use of Nonsteroidal Anti-inflammatory Drugs and Oral Anticoagulants Places Elderly Persons at High Risk for Hemorrhagic Peptic Ulcer Disease","volume":"153","author":"Shorr","year":"1993","journal-title":"Arch. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1111\/bcp.15371","article-title":"Does coprescribing nonsteroidal anti-inflammatory drugs and oral anticoagulants increase the risk of major bleeding, stroke and systemic embolism?","volume":"88","author":"Penner","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"111455","DOI":"10.1016\/j.exger.2021.111455","article-title":"Describing the relationship between atrial fibrillation and frailty: Clinical implications and open research questions","volume":"152","author":"Proietti","year":"2021","journal-title":"Exp. Gerontol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"afac192","DOI":"10.1093\/ageing\/afac192","article-title":"Epidemiology and impact of frailty in patients with atrial fibrillation in Europe","volume":"51","author":"Proietti","year":"2022","journal-title":"Age Ageing"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1055\/s-0038-1675400","article-title":"Predicting Thromboembolic and Bleeding Event Risk in Patients with Non-Valvular Atrial Fibrillation: A Systematic Review","volume":"118","author":"Borre","year":"2018","journal-title":"Thromb. Haemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e001187","DOI":"10.1136\/openhrt-2019-001187","article-title":"Twelve-month outcome in patients with stroke and atrial fibrillation not suitable to oral anticoagulant strategy: The WATCH-AF registry","volume":"6","author":"Guidoux","year":"2019","journal-title":"Open Heart"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e2752","DOI":"10.1002\/brb3.2752","article-title":"Antithrombotics prescription and adherence among stroke survivors: A systematic review and meta-analysis","volume":"12","author":"Yang","year":"2022","journal-title":"Brain Behav."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4070\/kcj.2019.0234","article-title":"Reducing Stroke Risk in Atrial Fibrillation: Adherence to Guidelines Has Improved, but Patient Persistence with Anticoagulant Therapy Remains Suboptimal","volume":"49","author":"Lowres","year":"2019","journal-title":"Korean Circ. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/bmj.331.7514.439","article-title":"Should a patient with primary intracerebral haemorrhage receive antiplatelet or anticoagulant therapy?","volume":"331","author":"Wani","year":"2005","journal-title":"BMJ"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1177\/2042098611415457","article-title":"Antithrombotic medicines following intracerebral haemorrhage: Where\u2019s the evidence?","volume":"2","author":"Flynn","year":"2011","journal-title":"Ther. Adv. Drug Saf."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1212\/WNL.59.2.205","article-title":"Long-term prognosis after recovery from primary intracerebral hemorrhage","volume":"59","author":"Vermeer","year":"2002","journal-title":"Neurology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/STROKEAHA.122.036884","article-title":"Cardiovascular Events After Intracerebral Hemorrhage","volume":"53","author":"Li","year":"2022","journal-title":"Stroke"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"17151","DOI":"10.1038\/s41598-022-22090-7","article-title":"Risk factors for stroke recurrence in patients with hemorrhagic stroke","volume":"12","author":"Wong","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1755-5922.2009.00118.x","article-title":"Systematic Review of Observational Research Studying the Long-Term use of Antithrombotic Medicines Following Intracerebral Hemorrhage","volume":"28","author":"Flynn","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1017\/S0266462305270198","article-title":"What is the best imaging strategy for acute stroke?","volume":"21","author":"Wardlaw","year":"2005","journal-title":"Int. J. Technol. Assess. Health Care"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1212\/WNL.56.6.773","article-title":"Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage","volume":"56","author":"Bailey","year":"2001","journal-title":"Neurology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/jnnp-2019-322663","article-title":"Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: Population-based study","volume":"91","author":"Li","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1212\/01.wnl.0000194267.09060.77","article-title":"Antiplatelet use after intracerebral hemorrhage","volume":"66","author":"Viswanathan","year":"2006","journal-title":"Neurology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","article-title":"American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2018 Update: A Report from the American Heart Association","volume":"137","author":"Benjamin","year":"2018","journal-title":"Circulation"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/STROKEAHA.110.611905","article-title":"Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurrence","volume":"42","author":"Broderick","year":"2011","journal-title":"Stroke"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1161\/STROKEAHA.117.018140","article-title":"Effects of Statin Intensity and Adherence on the Long-Term Prognosis after Acute Ischemic Stroke","volume":"48","author":"Kim","year":"2017","journal-title":"Stroke"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/ane.12813","article-title":"Non-persistence in ischaemic stroke: Risk of recurrent vascular events","volume":"137","author":"Rijkmans","year":"2018","journal-title":"Acta Neurol. Scand."},{"key":"ref_41","first-page":"1416","article-title":"The Role of NOACs in Atrial Fibrillation Management: A Qualitative Study","volume":"9","author":"Kirley","year":"2016","journal-title":"J. Atr. Fibrillation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jamacardio.2015.0374","article-title":"Oral Anticoagulant Therapy Prescription in Patients with Atrial Fibrillation Across the Spectrum of Stroke Risk","volume":"1","author":"Hsu","year":"2016","journal-title":"JAMA Cardiol."},{"key":"ref_43","first-page":"1400","article-title":"Underprescribing vs underfilling to oral anticoagulation: An analysis of linked medical record and claims data for a nationwide sample of patients with atrial fibrillation","volume":"28","author":"Guo","year":"2022","journal-title":"J. Manag. Care Sp\u00e9c. Pharm."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"afac064","DOI":"10.1093\/ageing\/afac064","article-title":"Prevalence and implications of frailty in acute stroke: Systematic review & meta-analysis","volume":"51","author":"Burton","year":"2022","journal-title":"Age Ageing"},{"key":"ref_45","unstructured":"Conroy, S., Carpenter, C., and Banerjee, J. (2023, November 01). Silver Book II: Quality Care for Older People with Urgent Care Needs. Available online: https:\/\/www.bgs.org.uk\/resources\/resource-series\/silver-book-ii."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3389\/fneur.2017.00275","article-title":"Pre-Stroke Modified Rankin Scale: Evaluation of Validity, Prognostic Accuracy, and Association with Treatment","volume":"8","author":"Quinn","year":"2017","journal-title":"Front. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Rockwood, K., and Howlett, S.E. (2018). Fifteen years of progress in understanding frailty and health in aging. BMC Med., 16.","DOI":"10.1186\/s12916-018-1223-3"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ageing\/afaa265","article-title":"Atrial fibrillation and oral anticoagulation in older people with frailty: A nationwide primary care electronic health records cohort study","volume":"50","author":"Wilkinson","year":"2021","journal-title":"Age Ageing"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ageing\/afy180","article-title":"Management of atrial fibrillation for older people with frailty: A systematic review and meta-analysis","volume":"48","author":"Wilkinson","year":"2019","journal-title":"Age Ageing"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Wilkinson, C., Wu, J., Searle, S.D., Todd, O., Hall, M., Kunadian, V., Clegg, A., Rockwood, K., and Gale, C.P. (2020). Clinical outcomes in patients with atrial fibrillation and frailty: Insights from the ENGAGE AF-TIMI 48 trial. BMC Med., 18.","DOI":"10.1186\/s12916-020-01870-w"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e014686","DOI":"10.1161\/JAHA.119.014686","article-title":"Accumulation of Deficits as a Key Risk Factor for Cardiovascular Morbidity and Mortality: A Pooled Analysis of 154,000 Individuals","volume":"9","author":"Farooqi","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Stow, D., Matthews, F.E., and Hanratty, B. (2018). Frailty trajectories to identify end of life: A longitudinal population-based study. BMC Med., 16.","DOI":"10.1186\/s12916-018-1148-x"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"e031341","DOI":"10.1136\/bmjopen-2019-031341","article-title":"Appropriateness of initial dose of non-vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation in the UK","volume":"9","author":"Vora","year":"2019","journal-title":"BMJ Open"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1056\/NEJMoa2012883","article-title":"Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation","volume":"383","author":"Okumura","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","article-title":"Blood-brain barrier dysfunction and recovery after ischemic stroke","volume":"163\u2013164","author":"Jiang","year":"2018","journal-title":"Prog. Neurobiol."},{"key":"ref_58","first-page":"e38","article-title":"Stroke Statistics Subcommittee (2016). Heart Disease and Stroke Statistics-2016 Update: A Report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s12975-016-0459-5","article-title":"Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke","volume":"7","author":"Liu","year":"2016","journal-title":"Transl. Stroke Res."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2174\/1567202611666140530145643","article-title":"Early Ischemic Blood Brain Barrier Damage: A Potential Indicator for Hemorrhagic Transformation Following Tissue Plasminogen Activator (tPA) Thrombolysis?","volume":"11","author":"Jin","year":"2014","journal-title":"Curr. Neurovasc. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic Transformation after Ischemic Stroke in Animals and Humans","volume":"34","author":"Jickling","year":"2013","journal-title":"J. Cereb. Blood Flow Metab. Off. J. Int. Soc. Cereb. Blood Flow Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1007\/s12035-014-8952-x","article-title":"Hemorrhagic Transformation after Tissue Plasminogen Activator Reperfusion Therapy for Ischemic Stroke: Mechanisms, Models, and Biomarkers","volume":"52","author":"Wang","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jns.2014.09.036","article-title":"Effects of tissue plasminogen activator timing on blood\u2013brain barrier permeability and hemorrhagic transformation in rats with transient ischemic stroke","volume":"347","author":"Zhang","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1161\/STROKEAHA.116.014839","article-title":"Lacunar Infarcts and Intracerebral Hemorrhage Differences: A Nested Case-Control Analysis in the FHS (Framingham Heart Study)","volume":"48","author":"Lioutas","year":"2017","journal-title":"Stroke"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/jamaneurol.2020.1512","article-title":"Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016","volume":"77","author":"Lioutas","year":"2020","journal-title":"JAMA Neurol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0885066613488732","article-title":"Intracerebral Hemorrhage in Patients Receiving Oral Anticoagulation Therapy","volume":"30","author":"Provencio","year":"2015","journal-title":"J. Intensiv. Care Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1161\/STROKEAHA.118.021799","article-title":"Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage","volume":"49","author":"Murphy","year":"2018","journal-title":"Stroke"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e12668","DOI":"10.1002\/rth2.12668","article-title":"Atrial fibrillation, liver cirrhosis, thrombosis, and bleeding: A Danish population-based cohort study","volume":"6","author":"Riahi","year":"2022","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"105946","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105946","article-title":"Association of Left Ventricular Hypertrophy and Atrial Fibrillation with Hemorrhagic Evolution of Small Vessel Disease","volume":"30","author":"Muscari","year":"2021","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/2396987321994296","article-title":"Risk of intracerebral haemorrhage from hypertension is greatest at an early age","volume":"6","author":"Stanton","year":"2021","journal-title":"Eur. Stroke J."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00234-019-02180-6","article-title":"Risk factors of intracranial hemorrhage after mechanical thrombectomy of anterior circulation ischemic stroke","volume":"61","author":"Neuberger","year":"2019","journal-title":"Neuroradiology"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1079205","DOI":"10.3389\/fneur.2023.1079205","article-title":"Risk factors of hemorrhagic transformation in acute ischaemic stroke: A systematic review and meta-analysis","volume":"14","author":"Sun","year":"2023","journal-title":"Front. Neurol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1161\/01.STR.30.7.1326","article-title":"Hemorrhagic transformation in acute ischemic stroke. The MAST-E study. MAST-E Group","volume":"30","author":"Jaillard","year":"1999","journal-title":"Stroke"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3389\/fneur.2019.00818","article-title":"There Is No Association Between the Number of Stent Retriever Passes and the Incidence of Hemorrhagic Transformation for Patients Undergoing Mechanical Thrombectomy","volume":"10","author":"Hassan","year":"2019","journal-title":"Front. Neurol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00234-021-02795-8","article-title":"Predicting hemorrhagic transformation after thrombectomy in acute ischemic stroke: A multimodal score of the regional pial collateral","volume":"64","author":"Yu","year":"2021","journal-title":"Neuroradiology"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1161\/STROKEAHA.120.030173","article-title":"Symptomatic intracranial hemorrhage after mechanical thrombectomy in Chinese ischemic stroke patients: The Asian Score","volume":"51","author":"Zhang","year":"2020","journal-title":"Stroke"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1161\/STROKEAHA.112.655621","article-title":"Intravenous thrombolysis and endovascular therapy for acute ischemic stroke with internal carotid artery occlusion: A systematic review of clinical outcomes","volume":"43","author":"Mokin","year":"2012","journal-title":"Stroke"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/neurintsurg-2021-018017","article-title":"Mechanical thrombectomy versus intravenous alteplase alone in acute isolated posterior cerebral artery occlusion: A systematic review","volume":"14","author":"Monteiro","year":"2022","journal-title":"J. NeuroInterv. Surg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2021.4.FOCUS21139","article-title":"Mechanical thrombectomy versus intravenous thrombolysis for distal large-vessel occlusion: A systematic review and meta-analysis of observational studies","volume":"51","author":"Waqas","year":"2021","journal-title":"Neurosurg. Focus"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/01.STR.32.5.1079","article-title":"Timing of Spontaneous Recanalization and Risk of Hemorrhagic Transformation in Acute Cardioembolic Stroke","volume":"32","author":"Molina","year":"2001","journal-title":"Stroke"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Iancu, A., Buleu, F., Chita, D.S., Tutelca, A., Tudor, R., and Brad, S. (2023). Early Hemorrhagic Transformation after Reperfusion Therapy in Patients with Acute Ischemic Stroke: Analysis of Risk Factors and Predictors. Brain Sci., 13.","DOI":"10.3390\/brainsci13050840"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"NINDS t-PA Stroke Study Group (1997). Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke, 28, 2109\u20132118.","DOI":"10.1161\/01.STR.28.11.2109"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/hs0302.104110","article-title":"Predictors of hemorrhagic trans-formation in patients receiving intra-arterial thrombolysis","volume":"33","author":"Kidwell","year":"2002","journal-title":"Stroke"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1212\/WNL.96.15_supplement.1644","article-title":"Predictors of Hemorrhagic Transformation After Mechanical Thrombectomy in Acute Ischemic Stroke (1644)","volume":"96","author":"Luo","year":"2021","journal-title":"Neurology"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"727304","DOI":"10.3389\/fneur.2021.727304","article-title":"Predictors and Prognosis of Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke Patients Without Thrombolysis: Analysis of Data from the Chinese Acute Ischemic Stroke Treatment Outcome Registry","volume":"12","author":"Shen","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"703258","DOI":"10.3389\/fneur.2021.703258","article-title":"Hemorrhagic Transformation After Ischemic Stroke: Mechanisms and Management","volume":"12","author":"Hong","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_87","first-page":"e100013","article-title":"Comorbidity and age in the modeling of stroke: Are we still failing to consider the characteristics of stroke patients?","volume":"4","author":"McCann","year":"2020","journal-title":"BMJ Open Sci."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/01.STR.30.1.34","article-title":"Serum Glucose Level and Diabetes Predict Tissue Plasminogen Activator\u2013Related Intracerebral Hemorrhage in Acute Ischemic Stroke","volume":"30","author":"Demchuk","year":"1999","journal-title":"Stroke"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Jurcau, A., and Ardelean, A.I. (2022). Oxidative Stress in Ischemia\/Reperfusion Injuries following Acute Ischemic Stroke. Biomedicines, 10.","DOI":"10.3390\/biomedicines10030574"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Janaszak-Jasiecka, A., P\u0142oska, A., Wiero\u0144ska, J.M., Dobrucki, L.W., and Kalinowski, L. (2023). Endothelial dysfunction due to eNOS uncoupling: Molecular mechanisms as potential therapeutic targets. Cell. Mol. Biol. Lett., 28.","DOI":"10.1186\/s11658-023-00423-2"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.jcbfm.9600355","article-title":"Hyperglycemia in Acute Ischemic Stroke: A Vascular Perspective","volume":"27","author":"Martini","year":"2007","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/2013.jamaneurol.547","article-title":"Timing of Recanalization After Intravenous Thrombolysis and Functional Outcomes After Acute Ischemic Stroke","volume":"70","author":"Yeo","year":"2013","journal-title":"JAMA Neurol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.STR.0000257314.74853.2b","article-title":"Asso-ciation of pretreatment blood pressure with tissue plasminogen activator-induced arterial recanalization in acute ischemic stroke","volume":"38","author":"Tsivgoulis","year":"2007","journal-title":"Stroke"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/23969873231173274","article-title":"Admission blood pressure and clinical outcomes in patients with acute ischaemic stroke treated with intravenous alteplase and endovascular treatment versus endovascular treatment alone: A MR CLEAN-NO IV substudy","volume":"8","author":"LeCouffe","year":"2023","journal-title":"Eur. Stroke J."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"XLVIII","DOI":"10.1177\/23969873211012133","article-title":"European Stroke Organisation (ESO) guidelines on blood pressure management in acute ischaemic stroke and intracerebral haemorrhage","volume":"6","author":"Sandset","year":"2021","journal-title":"Eur. Stroke J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1161\/STROKEAHA.120.029907","article-title":"Admission Blood Pressure in Relation to Clinical Outcomes and Successful Reperfusion After Endovascular Stroke Treatment","volume":"51","author":"Berg","year":"2020","journal-title":"Stroke"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/STROKEAHA.119.027549","article-title":"Blood Pressure Variability and Neurologic Outcome After Endovascular Thrombectomy: A Secondary Analysis of the BEST Study","volume":"51","author":"Mistry","year":"2020","journal-title":"Stroke"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.01.010","article-title":"Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial","volume":"25","author":"Krishnan","year":"2016","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.1161\/STROKEAHA.120.029959","article-title":"Risk of Ischemic Stroke in Patients with Atrial Fibrillation After Extracranial Hemorrhage","volume":"51","author":"Zhou","year":"2020","journal-title":"Stroke"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000504191","article-title":"The Correlation between Atrial Fibrillation and Prognosis and Hemorrhagic Transformation","volume":"82","author":"Dang","year":"2019","journal-title":"Eur. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"e28155","DOI":"10.1097\/MD.0000000000028155","article-title":"The clinical and neuroradiological features of patients of coexisting atraumatic convexity subarachnoid hemorrhage and large artery atherosclerosis stroke: A retrospective observational study","volume":"100","author":"Chai","year":"2021","journal-title":"Medicine"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1212\/WNL.0b013e3181d55efa","article-title":"Atraumatic convexal subarachnoid hemorrhage: Clinical presentation, imaging patterns, and etiologies","volume":"74","author":"Kumar","year":"2010","journal-title":"Neurology"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jns.2014.11.031","article-title":"Convexity subarachnoid hemorrhage in ischemic stroke","volume":"348","author":"Usmani","year":"2015","journal-title":"J. Neurol. Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.12.046","article-title":"Nontraumatic convexal subarachnoid hemorrhage concomitant with acute ischemic stroke","volume":"23","author":"Nakajima","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e5968","DOI":"10.1002\/ccr3.5968","article-title":"Acute ischemic stroke and convexity subarachnoid hemorrhage in large vessel atherosclerotic stenosis: Case series and review of the literature","volume":"10","author":"Safan","year":"2022","journal-title":"Clin. Case Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.12.028","article-title":"Subarachnoid Hemorrhage with Progressive Cerebral Steno-Occlusive Disease: Report of 2 Cases","volume":"28","author":"Takamiya","year":"2019","journal-title":"J. Stroke Cerebrovasc. Dis. Off. J. Natl. Stroke Assoc."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/ene.12926","article-title":"Distinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage","volume":"23","author":"Fugate","year":"2016","journal-title":"Eur. J. Neurol."},{"key":"ref_108","first-page":"1419","article-title":"Convexal subarachnoid hemorrhage and acute ischemic stroke: A border zone matter?","volume":"40","author":"Introna","year":"2019","journal-title":"Neurol. Sci. Off. J. Ital. Neurol. Soc. Ital. Soc. Clin. Neurophysiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s13760-022-02115-8","article-title":"Primary acute convexity subarachnoid hemorrhage in older patients: Analysis of baseline, clinical and MRI characteristics including quantitative surface study and topographical probabilistic mapping of convexity subarachnoid hemorrhage","volume":"123","author":"Autieri","year":"2023","journal-title":"Acta Neurol. Belg."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.atherosclerosis.2018.06.876","article-title":"Cirrhosis and risk of stroke: A systematic review and meta-analysis","volume":"275","author":"Xiong","year":"2018","journal-title":"Atherosclerosis"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/MCG.0000000000001201","article-title":"Risk of Stroke in Liver Cirrhosis: A Systematic Review and Meta-Analysis","volume":"54","author":"Zheng","year":"2020","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1007\/s00415-021-10441-9","article-title":"Cerebrovascular manifestations in hematological diseases: An update","volume":"268","author":"Ferro","year":"2021","journal-title":"J. Neurol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"105069","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105069","article-title":"Hemorrhagic stroke associated with essential thrombocythemia: Case report and literature review","volume":"29","author":"Momozaki","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00415-019-09347-4","article-title":"Specific mechanisms of subarachnoid hemorrhage accompanied by ischemic stroke in essential thrombocythemia: Two case reports and a literature review","volume":"266","author":"Sugiyama","year":"2019","journal-title":"J. Neurol."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41408-017-0042-7","article-title":"Polycythemia vera treatment algorithm 2018","volume":"8","author":"Tefferi","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41408-017-0041-8","article-title":"Essential thrombocythemia treatment algorithm 2018","volume":"8","author":"Tefferi","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clml.2017.09.008","article-title":"The Epidemiology and Clinical Associations of Stroke in Patients with Acute Myeloid Leukemia: A Review of 10,972 Admissions From the 2012 National Inpatient Sample","volume":"18","author":"Kim","year":"2018","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.wneu.2020.06.091","article-title":"Outcomes and Clinical Characteristics of Intracranial Hemorrhage in Patients with Hematologic Malignancies: A Systematic Literature Review","volume":"144","author":"Raghavan","year":"2020","journal-title":"World Neurosurg."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1016\/S0049-3848(20)30399-6","article-title":"Advances in the management of coagulopathy in acute promyelocytic leukemia","volume":"191","author":"Sanz","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1038\/s41467-019-13120-6","article-title":"Stroke among cancer patients","volume":"10","author":"Zaorsky","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1136\/practneurol-2019-002205","article-title":"Multiple myeloma with multiple neurological presentations","volume":"19","author":"Smith","year":"2019","journal-title":"Pract. Neurol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"104683","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104683","article-title":"Cerebral Venous Thrombosis in Hematological Malignancy: Balancing the Risks","volume":"29","author":"Pinto","year":"2020","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"Fotiou, D., Gavriatopoulou, M., and Terpos, E. (2020). Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools. Cancers, 12.","DOI":"10.3390\/cancers12010191"},{"key":"ref_124","first-page":"5180424","article-title":"Case of Stroke from Cerebral Vasculitis following Carfilzomib, Lenalidomide, and Dexamethasone Therapy in a Patient with Relapsing Multiple Myeloma","volume":"2019","author":"Osafehinti","year":"2019","journal-title":"Case Rep. Hematol."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.017","article-title":"Immune-Thrombotic Thrombocytopenic Purpura is a Rare Cause of Ischemic Stroke in Young Adults: Case Reports and Literature Review","volume":"27","author":"Tomich","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13318-018-0501-y","article-title":"Clinical Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants in Patients with Renal Failure","volume":"44","author":"Padrini","year":"2019","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s40620-022-01413-x","article-title":"A systematic review of the efficacy and safety of anticoagulants in advanced chronic kidney disease","volume":"35","author":"Parker","year":"2022","journal-title":"J. Nephrol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/rth2.12083","article-title":"Safety and effectiveness of apixaban compared to warfarin in dialysis patients","volume":"2","author":"Reed","year":"2018","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/1060028017694654","article-title":"Safety Outcomes of Apixaban Compared with Warfarin in Patients With End-Stage Renal Disease","volume":"51","author":"Sarratt","year":"2017","journal-title":"Ann. Pharmacother."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jacc.2019.10.059","article-title":"Oral Anticoagulation for Patients with Atrial Fibrillation on Long-Term Dialysis","volume":"75","author":"Kuno","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/bjh.15144","article-title":"Is anticoagulating haemodialysis patients with non-valvular atrial fibrillation too risky?","volume":"181","author":"Parker","year":"2018","journal-title":"Br. J. Haematol."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"RAF and RENO-EXTEND Investigators, Caliandro, P., Cancelloni, V., Marco, M., Reale, G., Zauli, A., Agnelli, G., Caso, V., Becattini, C., and Calabresi, P. (2023). Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy. Eur. Stroke J., 8, 722\u2013730.","DOI":"10.1177\/23969873231183211"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Purrucker, J.C., H\u00f6lscher, K., Kollmer, J., and Ringleb, P.A. (2020). Etiology of Ischemic Strokes of Patients with Atrial Fibrillation and Therapy with Anticoagulants. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092938"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/CIRCULATIONAHA.118.035864","article-title":"Stroke Outcomes in the COMPASS Trial","volume":"139","author":"Sharma","year":"2019","journal-title":"Circulation"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(17)32409-1","article-title":"Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: An international, randomised, double-blind, placebo-controlled trial","volume":"391","author":"Anand","year":"2018","journal-title":"Lancet"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11239-016-1425-5","article-title":"Combined aspirin and anticoagulant therapy in patients with atrial fibrillation","volume":"43","author":"So","year":"2017","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.hest.2021.12.002","article-title":"Severe stroke in patients admitted to intensive care unit after COVID-19 infection: Pictorial essay of a case series","volume":"3","author":"Deana","year":"2022","journal-title":"Brain Hemorrhages"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/jth.14938","article-title":"Macrothrombosis and stroke in patients with mild COVID-19 infection","volume":"18","author":"Fara","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1747493020972922","article-title":"Stroke in COVID-19: A systematic review and meta-analysis","volume":"16","author":"Nannoni","year":"2021","journal-title":"Int. J. Stroke"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"571996","DOI":"10.3389\/fneur.2020.571996","article-title":"COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"153","DOI":"10.5114\/ait.2021.105783","article-title":"COVID-19: Coagulation disorders and anticoagulant treatment in patients hospitalised in ICU","volume":"53","author":"Pluta","year":"2021","journal-title":"Anaesthesiol. Intensiv. Ther."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/bloodadvances.2021005945","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: July 2021 update on postdischarge thromboprophylaxis","volume":"6","author":"Cuker","year":"2022","journal-title":"Blood Adv."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"100919","DOI":"10.1016\/j.accpm.2021.100919","article-title":"Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on perioperative haemostasis (GIHP) and the French study group on thrombosis and haemostasis (GFHT), in collaboration with the French society of anaesthesia and intensive care (SFAR)","volume":"40","author":"Godon","year":"2021","journal-title":"Anaesth. Crit. Care Pain Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Varga","year":"2020","journal-title":"Lancet"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"607221","DOI":"10.3389\/fneur.2020.607221","article-title":"COVID-19 Pathophysiology Predicts That Ischemic Stroke Occurrence Is an Expectation, Not an Exception\u2014A Systematic Review","volume":"11","author":"Wijeratne","year":"2021","journal-title":"Front. Neurol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1016\/j.wneu.2021.07.067","article-title":"Intracranial Hemorrhage in Patients with Coronavirus Disease 2019 (COVID-19): A Case Series","volume":"154","author":"Abbas","year":"2021","journal-title":"World Neurosurg."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"100669","DOI":"10.1016\/j.nmni.2020.100669","article-title":"COVID-19 and intracerebral haemorrhage: Causative or coincidental?","volume":"35","author":"Karimi","year":"2020","journal-title":"New Microbes New Infect."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in COVID-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.atherosclerosis.2021.02.009","article-title":"Coronavirus disease-19: The multi-level, multi-faceted vasculopathy","volume":"322","author":"Quinaglia","year":"2021","journal-title":"Atherosclerosis"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Sagris, M., Theofilis, P., Antonopoulos, A.S., Tsioufis, C., Oikonomou, E., Antoniades, C., Crea, F., Kaski, J.C., and Tousoulis, D. (2021). Inflammatory Mechanisms in COVID-19 and Atherosclerosis: Current Pharmaceutical Perspectives. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126607"}],"container-title":["Neurology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2035-8377\/15\/4\/93\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:35:16Z","timestamp":1760132116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2035-8377\/15\/4\/93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":150,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["neurolint15040093"],"URL":"https:\/\/doi.org\/10.3390\/neurolint15040093","relation":{},"ISSN":["2035-8377"],"issn-type":[{"value":"2035-8377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]}}}